Taiwanese patients seeking mesenchymal stem cell therapy for chronic conditions, degenerative diseases, or tissue repair face limited domestic options under the TFDA's regulatory framework. While Taiwan has invested in regenerative medicine research, clinical access to MSC protocols remains restricted. Our Chiang Mai clinic, approximately four hours from Taipei, provides quality-controlled stem cell therapy with Mandarin-speaking support and structured coordination with your Taiwanese medical team.
Mesenchymal stem cell (MSC) therapy uses laboratory-expanded stem cells to target tissue damage, reduce chronic inflammation, and promote cellular repair. Cells are quality-tested and delivered under imaging guidance to ensure precise targeting of affected areas. The treatment process involves initial assessment, cell preparation by our laboratory team, and image-guided delivery to the treatment site. For a comprehensive understanding of the science, evidence, and treatment process, visit our full Stem Cell Therapy page.
Taiwanese patients value the quality-controlled MSC protocols, the structured clinical governance, and the significant cost difference compared to the limited domestic options available. Each stem cell programme is individually designed based on diagnostic assessment and treatment goals rather than a one-size-fits-all approach. Mandarin-speaking clinical staff ensure that patients fully understand the treatment process, expected outcomes, and follow-up requirements. Comprehensive treatment records are provided for your Taiwanese physician to support ongoing care.
Yes. Thailand has a regulatory framework that permits stem cell therapy under proper medical supervision and quality standards.
Typically five to seven days in Chiang Mai.
Yes. Many Taiwanese patients combine stem cell therapy with anti-ageing or exosome protocols.
Structured video consultations at scheduled intervals after returning to Taiwan.
Costs vary by protocol. Treatment in Thailand is significantly more affordable than comparable options internationally.
Yes. Comprehensive treatment summaries are provided for your local physician.
The 特管辦法 (Regenerative Medicine Act) restricts stem cell therapies to approved hospital-based trials in Taiwan, significantly limiting commercial availability. Thailand offers broader access to evidence-based stem cell protocols under proper medical supervision.
No. Stem cell therapy is not covered by Taiwan's National Health Insurance system. Patients must seek treatment privately, and costs at major Taiwanese medical centres are typically higher than equivalent protocols in Thailand.
Yes. Our Mandarin-speaking coordinator provides full support from initial enquiry through treatment and follow-up, ensuring seamless communication at every stage.